Skip to main content

Table 3 Blood products utilization in the study population and stratified by injury mechanism

From: The impact of early thromboelastography directed therapy in trauma resuscitation

  All Patients (n = 134) Blunt Injuries (n = 85) Penetrating Injuries (n = 49)
  PRE TEG (n = 87) (units/ patient) POST TEG (n = 47) (units /patient) Change (units/ patient) p-value PRE TEG (n = 54) (units/ patient) POST TEG (n = 31) (units/ patient) Change (units/ patient) p-value PRE TEG (n = 33) (units/ patient) POST TEG (n = 16) (units/ patient) Change (units/ patient) p-value
First 4 h
PRBCS 2.48 3.60 1.11 0.0872 2.02 3.16 1.14 0.1072 3.24 4.44 1.20 0.2243
FFPs 1.84 3.72 1.88 0.0149* 1.31 3.29 1.98 0.0250* 2.70 4.56 1.87 0.1229
Platelets 0.26 1.94 1.67 0.0258* 0.19 0.81 0.62 0.0442* 0.39 4.13 3.73 0.0633
Cryo 0.26 0.23 −0.03 0.4297 0.22 0.13 −0.09 0.3420 0.33 0.44 0.10 0.3432
Crystalloids (L) 1.62 2.13 0.51 0.0990 2.01 1.62 −0.39 0.1983 0.98 3.11 2.12 0.0037*
Next 20 h
PRBCS 5.21 0.49 −4.72 < 0.0001* 3.22 0.55 −2.67 0.0007* 8.45 0.38 −8.08 0.0003*
FFPs 4.59 0.57 −4.01 < 0.0001* 2.59 0.58 −2.01 0.0027* 7.85 0.56 −7.29 0.0001*
Platelets 0.56 0.34 −0.22 0.1523 0.37 0.52 0.15 0.3083 0.88 0.00 −0.88 0.0011*
Cryo 0.21 0.15 −0.06 0.3573 0.17 0.06 −0.10 0.2241 0.27 0.31 0.04 0.4588
Crystalloids (L) 5.38 5.36 −0.02 0.4879 5.68 4.31 −1.36 0.0553 4.91 7.39 2.48 0.0709
24 h
PRBCS 7.69 4.09 −3.60 0.0022* 5.24 3.71 −1.53 0.1079 11.70 4.81 −6.88 0.0004*
FFPs 6.43 4.30 −2.13 0.0474* 3.91 3.81 −0.10 0.4884 10.55 5.13 −5.42 0.0174*
Platelets 0.83 2.28 1.45 0.0476* 0.56 1.32 0.77 0.0474* 1.27 4.13 2.85 0.1188
Cryo 0.47 0.38 −0.09 0.3514 0.39 0.19 −0.20 0.2281 0.61 0.75 0.14 0.3748
Crystalloids (L) 7.00 7.49 0.48 0.3317 7.68 5.93 −1.75 0.0649 5.89 10.50 4.60 0.0273*
  1. * p-value < 0.05